Literature DB >> 28932529

Bioresorbable scaffolds versus metallic stents in routine PCI: the plot thickens.

Athanasios Katsikis1, Patrick W Serruys2.   

Abstract

Year:  2017        PMID： 28932529      PMCID： PMC5594133          DOI： 10.21037/jtd.2017.07.72

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

1.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Authors:  Laura Mauri; Dean J Kereiakes; Robert W Yeh; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Sharon-Lise T Normand; Eugene Braunwald; Stephen D Wiviott; David J Cohen; David R Holmes; Mitchell W Krucoff; James Hermiller; Harold L Dauerman; Daniel I Simon; David E Kandzari; Kirk N Garratt; David P Lee; Thomas K Pow; Peter Ver Lee; Michael J Rinaldi; Joseph M Massaro
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

Authors:  Joanna J Wykrzykowska; Robin P Kraak; Sjoerd H Hofma; Rene J van der Schaaf; E Karin Arkenbout; Alexander J IJsselmuiden; Joëlle Elias; Ivo M van Dongen; Ruben Y G Tijssen; Karel T Koch; Jan Baan; M Marije Vis; Robbert J de Winter; Jan J Piek; Jan G P Tijssen; Jose P S Henriques
Journal:  N Engl J Med       Date:  2017-03-29       Impact factor: 91.245

3.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Authors:  Patrick W Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M Garcia-Garcia; Koen Nieman; Nico Bruining; Cécile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

4.  Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.

Authors:  Serban Puricel; Florim Cuculi; Melissa Weissner; Axel Schmermund; Peiman Jamshidi; Tobias Nyffenegger; Harald Binder; Holger Eggebrecht; Thomas Münzel; Stephane Cook; Tommaso Gori
Journal:  J Am Coll Cardiol       Date:  2016-03-01       Impact factor: 24.094

5.  Long-term data of BRS presented at EuroPCR 2017 (Friday, 19 May).

Authors:  Patrick W Serruys; Athanasios Katsikis; Yoshinobu Onuma
Journal:  EuroIntervention       Date:  2017-08-04       Impact factor: 6.534

6.  Dmax for sizing, PSP-1, PSP-2, PSP-3 or OCT guidance: interventionalist's jargon or indispensable implantation techniques for short- and long-term outcomes of Absorb BRS?

Authors:  Patrick W Serruys; Yoshinobu Onuma
Journal:  EuroIntervention       Date:  2017-04-20       Impact factor: 6.534

7.  Bioresorbable Vascular Scaffolds for Coronary Revascularization.

Authors:  Dean J Kereiakes; Yoshinobu Onuma; Patrick W Serruys; Gregg W Stone
Journal:  Circulation       Date:  2016-07-12       Impact factor: 29.690

8.  Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.

Authors:  W J van der Giessen; A M Lincoff; R S Schwartz; H M van Beusekom; P W Serruys; D R Holmes; S G Ellis; E J Topol
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

9.  Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

Authors:  Stephen G Ellis; Dean J Kereiakes; D Christopher Metzger; Ronald P Caputo; David G Rizik; Paul S Teirstein; Marc R Litt; Annapoorna Kini; Ameer Kabour; Steven O Marx; Jeffrey J Popma; Robert McGreevy; Zhen Zhang; Charles Simonton; Gregg W Stone
Journal:  N Engl J Med       Date:  2015-10-12       Impact factor: 91.245

Review 10.  Bioresorbable scaffolds: rationale, current status, challenges, and future.

Authors:  Javaid Iqbal; Yoshinobu Onuma; John Ormiston; Alexandre Abizaid; Ron Waksman; Patrick Serruys
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983
View more
  1 in total

1.  Bioresorbable stents: quo vantis?

Authors:  Nicholas G Kounis; Ioanna Koniari; Periklis Davlouros; George Soufras; Grigorios Tsigkas; George Hahalis
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.